LayerBio CEO Presents Strategy to Develop a Sustained-Release Glaucoma Product at MIT VMS Demo Day 2014

Dr. Ken Mandell, Founder and CEO of LayerBio, spoke at MIT's Venture Mentoring Service -- Demo Day 2014, an invitation-only event showcasing the latest start-up companies within the MIT community. In his presentation, Dr. Mandell discussed LayerBio's plans to develop a novel sustained-release therapy for treatment of glaucoma, the second leading cause of blindness worldwide.